Interleukin-2 in autologous bone marrow transplantation.
Article
in English
| IMSEAR
| ID: sea-118295
ABSTRACT
Interleukin-2 results in the generation of lymphokine activated killer cells which exhibit a potent effect against a wide variety of tumours. Consequently, interleukin-2 therapy has been used to induce a graft versus tumour effect following autologous bone marrow transplantation. Preclinical studies have shown that this results in successful engraftment, and an enhanced reconstitution of the immune system.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Transplantation, Autologous
/
Bone Marrow
/
Humans
/
Killer Cells, Lymphokine-Activated
/
Bone Marrow Transplantation
/
Interleukin-2
/
Cytotoxicity, Immunologic
/
Neoplasms
Language:
English
Year:
1993
Type:
Article
Similar
MEDLINE
...
LILACS
LIS